Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
ABCB1 encodes Multidrug Resistance Protein which promotes efflux of chemotherapeutic and targeted agents. Here, in breast and ovarian cancer the authors identify multiple transcriptional fusion partners involving ABCB1 that are associated with treatment failure and previous treatment regimens.
Saved in:
Main Authors: | Elizabeth L. Christie, Swetansu Pattnaik, Jessica Beach, Anthony Copeland, Nineveh Rashoo, Sian Fereday, Joy Hendley, Kathryn Alsop, Samuel L. Brady, Greg Lamb, Ahwan Pandey, Anna deFazio, Heather Thorne, Andrea Bild, David D. L. Bowtell |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/3d60dcd89a874c7d9dd75f1ea6c6ed3b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer
by: Kathleen I. Pishas, et al.
Published: (2021) -
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer
by: Aritro Nath, et al.
Published: (2021) -
A transportome-scale amiRNA-based screen identifies redundant roles of Arabidopsis ABCB6 and ABCB20 in auxin transport
by: Yuqin Zhang, et al.
Published: (2018) -
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
by: Mugosa Snezana, et al.
Published: (2021) -
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma
by: Durgagauri H. Sabnis, et al.
Published: (2019)